Does Vitamin D Deficiency Inhibit Anti–Tumor Necrosis Factor Therapy in Patients With Irritable Bowel Disease or Does It Simply Result From More Severe Disease?
Restricted accessLetterFirst published online November, 2014
Does Vitamin D Deficiency Inhibit Anti–Tumor Necrosis Factor Therapy in Patients With Irritable Bowel Disease or Does It Simply Result From More Severe Disease?
ZatorZACantuSMKonijetiGG. Pretreatment 25-hydroxyvitamin D levels and durability of anti–tumor necrosis factor–α therapy in inflammatory bowel diseases. JPEN J Parenter Enteral Nutr. 2014;38:385-391.
2.
MoodyGEadenJAMayberryJF. Social implications of childhood Crohn’s disease. J Pediatr Gastroenterol Nutr. 1999;28:S43-S45.
3.
SorensenVZOlsenBGBinderV. Life prospects and quality of life in patients with Crohn’s disease. Gut. 1987;28:382-385.
4.
JosephAJGeorgeBPulimoodAB. 25(OH) vitamin D level in Crohn’s disease: association with sun exposure & disease activity. Indian J Med Res. 2009;130:133-137.
